HIGHLIGHTS
- who: Yinan Yao et al. from the Department of Respiratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China have published the research: Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer, in the Journal: Journal of Immunology Research of 28/05/2022
- what: This study is aimed at investigating the biological effect of Th22 cells/IL-22 and its molecular mechanism in the pathogenesis process of non-small-cell lung cancer (NSCLC). This . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.